Gregory L. Damhorst, MD, PhD
Recent Publications
Damhorst GL, Martin SE, Wilber E, Verkerke H, Goodman M, Lam WA. Diagnostic Utility of SARS-CoV-2 Nucleocapsid Antigenemia: A Meta-analysis. Open Forum Infect Dis. 2024 Oct 2;11(10):ofae561. doi: 10.1093/ofid/ofae561. PMID: 39431150; PMCID: PMC11487748.
Bassit L, Bowers HB, Greenleaf M, Sabino C, Lai E, Yu G, Piantadosi A, Wang E, O'Sick W, McLendon K, Sullivan JA, Schinazi RF, Damhorst GL, Lam W, Rao A. Protocol for the creation and characterization of SARS-CoV-2 variant testing panels using remnant clinical samples for diagnostic assay testing. STAR Protoc. 2024 Jun 20;5(3):103146. doi: 10.1016/j.xpro.2024.103146. Epub ahead of print. PMID: 38905104.
G. L. Damhorst*, J. Lin*, J. K. Frediani*, J. A. Sullivan, A. Westbrook, K. McLendon, et al. Comparison of RT-PCR and antigen test sensitivity across nasopharyngeal, nares, and oropharyngeal swab, and saliva sample types during the SARS-CoV-2 omicron variant. Heliyon 2024 Vol. 10 Issue 6. DOI: 10.1016/j.heliyon.2024.e27188.
Damhorst GL, McLendon K, Morales E, Solis ZM, Fitts E, Bowers HB, Sabino C, Sullivan J, Greenleaf M, Roback JD, Colasanti JA, Sheth AN, Titanji BK, Martin GS, Bassit L, Lam WA, Rao A. Performance of the Xpert™ Mpox PCR assay with oropharyngeal, anorectal, and cutaneous lesion swab specimens. J Clin Virol. 2024 Apr;171:105659. doi: 10.1016/j.jcv.2024.105659. Epub 2024 Feb 23. PMID: 38430669.
Damhorst GL*, Fujita AW*, Fitts E, Szabo B, Bowers HB, Sabino C, Ahmed A, Wang E, Piantadosi A, McLendon K, Sullivan J, Greenleaf M, McCaslin D, Palmore M, Anderson AM, Aldred B, Gunthel C, Martin GS, Colasanti JA, Lam WA, Bassit L, Rao A, Sheth AN, Titanji BK. Multisite mpox infection and viral dynamics among persons with HIV in metro-Atlanta. J Infect Dis. 2023 Nov 29:jiad530. doi: 10.1093/infdis/jiad530. PMID: 38019187.
Cheedarla N, Verkerke HP, Potlapalli S, McLendon KB, Patel A, Frank F, O'Sick WH, Cheedarla S, Baugh TJ, Damhorst GL, Wu H, Graciaa D, Hudaib F, Alter DN, Bryksin J, Ortlund EA, Guarner J, Auld S, Shah S, Lam W, Mattoon D, Johnson JM, Wilson DH, Dhodapkar MV, Stowell SR, Neish AS, Roback JD. Rapid, high throughput, automated detection of SARS-CoV-2 neutralizing antibodies against Wuhan-WT, delta and omicron BA1, BA2 spike trimers. iScience. 2023 Oct 18;26(11):108256. doi: 10.1016/j.isci.2023.108256. PMID: 37965140; PMCID: PMC10641509.
Lancelot M, Fibben K, Sullivan J, O'Sick W, McLendon K, Wu H, Rao A, Bassit LC, Greenleaf M, Miller P, Krull W, Tyburski E, Roback JD, Lam WA*, Damhorst GL*. Effect of swab pooling on the Accula point-of-care RT-PCR for SARS-CoV-2 detection. Front Microbiol. 2023 Aug 7;14:1219214. doi: 10.3389/fmicb.2023.1219214. PMID: 37608952; PMCID: PMC10440424.
Mermin-Bunnell K, Zhu Y, Hornback A, Damhorst G, Walker T, Robichaux C, Mathew L, Jaquemet N, Peters K, Johnson TM 2nd, Wang MD, Anderson B. Use of Natural Language Processing of Patient-Initiated Electronic Health Record Messages to Identify Patients With COVID-19 Infection. JAMA Netw Open. 2023 Jul 3;6(7):e2322299. doi: 10.1001/jamanetworkopen.2023.22299. PMID: 37418261; PMCID: PMC10329205.
Damhorst GL, Schoof N, Nguyen PV, Verkerke H, Wilber E, McLendon K, O'Sick W, Baugh T, Cheedarla S, Cheedarla N, Stittleburg V, Fitts EC, Neja MA, Babiker A, Piantadosi A, Roback JD, Waggoner JJ, Mavigner M, Lam WA. Investigation of blood plasma viral nucleocapsid antigen as a marker of active SARS-CoV-2 Omicron variant infection, Open Forum Infect Dis. 2023 May 2;10(5):ofad226. doi: 10.1093/ofid/ofad226. PMID: 37213426; PMCID: PMC10199120.
Greenleaf MN, Nehl E, Damhorst GL, Lam WA. Pivot, persevere, or perish: how Ellume Health overcame development and regulatory obstacles to become the first authorized over-the-counter COVID-19 test in the United States. Lab Chip. 2023 May 2. doi: 10.1039/d3lc00118k. Epub ahead of print. PMID: 37129954.
*Shared first/last author